Dr. Sauter is Director of the Blood and Marrow Transplant program at Cleveland Clinic.  He also serves as the Co-Chair of the Lymphoma Working Committee in the Center for International Blood and Marrow Transplantation Research (CIBMTR) and has served as the Chairperson of the Tri-State Transplant Consortium (TSTC).  Currently, he is a member of the Case Comprehensive Cancer Center as part of the Immune Oncology Research Program and is a member of the National Center for Regenerative Medicine (NCRM).  Additionally, he is a member of the Cleveland Clinic Global Center for Immunotherapy (CITI).  His research has focused on improving the outcome of patients with relapsed and refractory (rel/ref) non-Hodgkin lymphoma (NHL) with hematopoietic cell transplantation (HCT) and cellular therapy.